Pregnancy and COVID-19 | Physiological Reviews
COVID-19 and Pregnancy: Risk, Symptoms, Diagnosis, and Treatment | SN Comprehensive Clinical Medicine
Call for a unified approach to Monkeypox infection in pregnancy: Lessons from the COVID-19 pandemic | Nature Communications
Frontiers | Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials
Full article: Remdesivir use in pregnancy during the SARS-CoV-2 pandemic
Processes | Free Full-Text | COVID-19-Current Therapeutical Approaches and Future Perspectives
Safety categories of potential COVID-19 drugs during pregnancy and... | Download Scientific Diagram
Biotransformation and transplacental transfer of the anti-viral remdesivir and predominant metabolite, GS-441524 in pregnant rats - eBioMedicine
Severe SARS‐CoV‐2 infection in a 32‐week pregnant woman treated with Remdesivir‐Dexamethasone combination therapy: A case report - Alavi - 2022 - Clinical Case Reports - Wiley Online Library
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 | ACS Central Science
9 Things You Need To Know About Molnupiravir, a New COVID-19 Pill > News > Yale Medicine
Biotransformation and transplacental transfer of the anti-viral remdesivir and predominant metabolite, GS-441524 in pregnant rats - eBioMedicine
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial - ScienceDirect
Full article: Safety and efficacy of anti-SARS-CoV-2 monoclonal antibodies in pregnancy
Frontiers | Detection of potential safety signals related to the use of remdesivir and tocilizumab in the COVID era during pregnancy, resorting to open data from the FDA adverse event reporting system (
The Incidence, Severity, and Management of COVID-19 in Critically Ill Pregnant Individuals - Ontario COVID-19 Science Advisory Table
Viruses | Free Full-Text | Remdesivir Use in the Real-World Setting: An Overview of Available Evidence
Safety of Medications During Pregnancy - Women's Health Issues - MSD Manual Consumer Version
The Lancet on X: "3/4 of #COVID19 trials reviewed specifically excluded expectant mothers, even though they were investigating medications and vitamins that already have a relatively favourable safety profile during pregnancy, or
